Efficiency of Tadalafil for Management of Female Sexual Dysfunction

Kasr El Aini Hospital

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Sexual Dysfunction

Treatments: Drug: Tadalafil 5mg; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT05266651

22022022

Details and patient eligibility

About

comparative study between tadalafil versus placebo effect for the management of circumsized female

Full description

the group of patient will be randomly divided into 2 groups, half of the patients will receive tadalafil and the other half will receive placebo

Enrollment: 24 estimated patients

Sex: Female

Ages: 25 to 35 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• female with history of female genital mutilation female with history of sexual dysfunction

Exclusion criteria

• any medical disorder

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

24 participants in 2 patient groups, including a placebo group

tadalafil group

Active Comparator group

Description:

5 mg of Tadalafil on daily bases for one month duration

Treatment:

Drug: Tadalafil 5mg

placebo group

Placebo Comparator group

Description:

the patients will receive oral tablets without any active substance for one month

Treatment:

Drug: Placebo